an inhibitor of gluconeogenesis at the phosphoenolpyruvate carboxykinase ( pep ck ) reaction , this agent has been shown in randomized , placebo-controlled , double-blind trials to improve glucose tolerance , reduce glucose turnover , increase caloric intake , and increase or stabilize weight ;
C0017715
gluconeogenesis
C0017725
glucose